Cargando…

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies

Inflammatory bowel disease (IBD) is a chronic and heterogeneous disorder characterized by remitting and relapsing periods of activity. Pharmacogenetics refers to the study of the effect of inheritance on individual variation in drug responses. Several drug-related markers in IBD patients have been i...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yamamoto-Furusho, Jesús K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457182/ https://www.ncbi.nlm.nih.gov/pubmed/28603427 http://dx.doi.org/10.2147/PGPM.S109648

Ejemplares similares

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review
por: Ribeiro, Aline C., et al.
Publicado: (2023)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021)

Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease
por: Bangma, Amber, et al.
Publicado: (2020)

Growth Factors as Treatment for Inflammatory Bowel Disease: A Concise Review of the Evidence Toward Their Potential Clinical Utility
por: Barahona-Garrido, Josué, et al.
Publicado: (2009)

Diagnostic Delay of Inflammatory Bowel Disease Is Significantly Higher in Public versus Private Health Care System in Mexican Patients
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2021)

Mortality and Hospitalizations in Mexican Patients with Inflammatory Bowel Disease: Results from a Nationwide Health Registry
por: Sarmiento-Aguilar, Andrea, et al.
Publicado: (2020)

Indoleamine 2,3-Dioxygenase: Expressing Cells in Inflammatory Bowel Disease—A Cross-Sectional Study
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2013)

Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics
por: Voskuil, Michiel Dirk, et al.
Publicado: (2019)

Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021)

Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations()
por: de León-Rendón, J.L., et al.
Publicado: (2020)

Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2021)

Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease
por: Fonseca-Camarillo, Gabriela, et al.
Publicado: (2018)

2375. Association Between Clostridium difficile Colonization and Inflammatory Bowel Disease Activity
por: Morado-Aramburo, Oscar, et al.
Publicado: (2019)

Pharmacogenetics and pharmacogenomics in glaucoma therapeutics: the way to personalized therapy
por: Liao, Shiyu, et al.
Publicado: (2023)

Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
por: Elhag, Duaa Ahmed, et al.
Publicado: (2022)

Multiple sclerosis pharmacogenetics: personalized approach towards tailored therapeutics
por: Grossman, Iris, et al.
Publicado: (2010)

Pharmacogenetics and personalized treatment of type 2 diabetes
por: Semiz, Sabina, et al.
Publicado: (2013)

The Unfolded Protein Response and Its Implications for Novel Therapeutic Strategies in Inflammatory Bowel Disease
por: Verjan Garcia, Noel, et al.
Publicado: (2023)

New Strategies for Treatment of Inflammatory Bowel Disease
por: Nielsen, Ole Haagen
Publicado: (2014)

Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization
por: Ong, Frank S., et al.
Publicado: (2013)

Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
por: Kakuta, Yoichi, et al.
Publicado: (2017)

Glossary: Definitions Useful in Understanding Pharmacogenetics
por: Farkas, D.
Publicado: (2008)

Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
por: Yue, Bei, et al.
Publicado: (2020)

Personalized Nutrition for Inflammatory Bowel Disease
por: Collins, Colm B, et al.
Publicado: (2020)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Pharmacogenetic and pharmacogenomic discovery strategies
por: Crisafulli, Concetta, et al.
Publicado: (2019)

Pharmacogenetics of Treatment Response in Psoriatic Arthritis
por: Jani, Meghna, et al.
Publicado: (2015)

Advanced Understanding of Monogenic Inflammatory Bowel Disease
por: Nambu, Ryusuke, et al.
Publicado: (2021)

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
por: Conti, Valeria, et al.
Publicado: (2020)

Inflammatory Bowel Disease: A Personalized Approach
por: Konidari, Anastasia, et al.
Publicado: (2021)

Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine
por: Kumar, Manoj, et al.
Publicado: (2019)

Stem cell therapeutics: potential in the treatment of inflammatory bowel disease
por: Swenson, ES, et al.
Publicado: (2010)

Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
por: Ashizuka, Shinya, et al.
Publicado: (2021)

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
por: Bretto, Elisabetta, et al.
Publicado: (2023)

Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease
por: Cayatte, Corinne, et al.
Publicado: (2012)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
por: Bernstein, Charles N, et al.
Publicado: (2020)

Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma
por: Goričar, Katja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e61ufcdnjso6jimt8g7fhev1pl